Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa

Malaria Journal

Volumn 15, Issue 1, 2016, Pages

  Slater, Hannah C ^a   Griffin, Jamie T ^a   Ghani, Azra C ^a   Okell, Lucy C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Artemisinin combination therapy; Artemisinin resistance; Modelling

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; ARTEMISININ DERIVATIVE;

AFRICA; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; ASIA; HEALTH IMPACT ASSESSMENT; INCIDENCE; MALARIA; MODEL; PARASITE CLEARANCE; PREVALENCE; REINFECTION; TREATMENT FAILURE; AFRICA SOUTH OF THE SAHARA; DRUG RESISTANCE; HUMAN;

AFRICA; AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; ARTEMISININS; ASIA; DRUG RESISTANCE; HUMANS; MALARIA;

EID: 84953325404     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/s12936-015-1075-7     Document Type: Article

References (30)

1. World Health Organization. Emergency response to artemisinin resistance in the Greater Mekong subregion: regional framework for action, 2013-2015. Geneva: World Health Organization; 2013. http://apps.who.int/iris/bitstream/10665/79940/1/9789241505321-eng.pdf.
2. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, et al. Spread of artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med. 2014;371:411-23.
3. Dondorp AM, Ringwald P. Artemisinin resistance is a clear and present danger. Trends Parasitol. 2013;29:359-60.
4. Naidoo I, Roper C. Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum. Trends Parasitol. 2010;26:447-56.
5. Ariey F, Witkowski B, Amaratunga C, Beghain J, Langlois AC, Khim N, et al. A molecular marker of artemisinin-resistant Plasmodium falciparum malaria. Nature. 2014;505:50-5.
6. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, et al. Independent emergence of artemisinin resistance mutations among Plasmodium falciparum in Southeast Asia. J Infect Dis. 2015;211:670-9.
7. Talundzic E, Okoth SA, Congpuong K, Plucinski MM, Morton L, Goldman IF, et al. Selection and spread of artemisinin-resistant alleles in Thailand prior to the global artemisinin resistance containment campaign. PLoS Pathog. 2015;11:e1004789.
8. Taylor SM, Parobek CM, DeConti DK, Kayentao K, Coulibaly SO, Greenwood BM, et al. Absence of putative artemisinin resistance mutations among Plasmodium falciparum in sub-Saharan Africa: a molecular epidemiologic study. J Infect Dis. 2015;211:680-8.
9. Kamau E, Campino S, Amenga-Etego L, Drury E, Ishengoma D, Johnson K, et al. K13-propeller polymorphisms in Plasmodium falciparum parasites from sub-Saharan Africa. J Infect Dis. 2015;211:1352-5.
10. Lubell Y, Dondorp A, Guerin P, Drake T, Meek S, Ashley E, et al. Artemisinin resistance - modelling the potential human and economic costs. Malar J. 2014;13:452.
11. Flegg J, Guerin P, White N, Stepniewska K. Standardizing the measurement of parasite clearance in falciparum malaria: the parasite clearance estimator. Malar J. 2011;10:339.
12. Krishna S, Kremsner PG. Antidogmatic approaches to artemisinin resistance: reappraisal as treatment failure with artemisinin combination therapy. Trends Parasitol. 2013;29:313-7.
13. Griffin JT, Hollingsworth TD, Okell LC, Churcher TS, White M, Hinsley W, et al. Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies. PLoS Med. 2010;7:e1000324.
14. Griffin JT, Ferguson NM, Ghani AC. Estimates of the changing age-burden of Plasmodium falciparum malaria disease in sub-Saharan Africa. Nat Commun. 2014;5:3136.
15. Francis D, Nsobya SL, Talisuna A, Yeka A, Kamya MR, Machekano R, et al. Geographic differences in antimalarial drug efficacy in Uganda are explained by differences in endemicity and not by known molecular markers of drug resistance. J Infect Dis. 2006;193:978-86.
16. Leang R, Barrette A, Bouth DM, Menard D, Abdur R, Duong S, et al. Efficacy of dihydroartemisinin-piperaquine for treatment of uncomplicated Plasmodium falciparum and Plasmodium vivax in Cambodia, 2008 to 2010. Antimicrob Agents Chemother. 2013;57:818-26.
17. Spring MD, Lin JT, Manning JE, Vanachayangkul P, Somethy S, Bun R, et al. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study. Lancet Infect Dis. 2015;15:683-91.
18. Bethell D, Se Y, Lon C, Tyner S, Saunders D, Sriwichai S, et al. Artesunate dose escalation for the treatment of uncomplicated malaria in a region of reported artemisinin resistance: a randomized clinical trial. PLoS One. 2011;6:e19283.
19. Naidoo I, Roper C. Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. Trends Parasitol. 2013;29:505-15.
20. Griffin JT, Hollingsworth TD, Reyburn H, Drakeley CJ, Riley EM, Ghani AC. Gradual acquisition of immunity to severe malaria with increasing exposure. Proc R Soc Lond B Biol Sci. 2015;282:20142657.
21. United Nations. Department of Economic and Social Affairs, Population Division. World Population Prospects, the 2010 Revision. http://esa.un.org/wpp/. Accessed Feb 2013. 2010.
22. Oak Ridge National Laboratory. LandScan high resolution global population data set. 2011. Available at http://www.ornl.gov/sci/landscan/. Accessed 12 May 2014.
23. Gething P, Patil A, Smith D, Guerra C, Elyazar I, Johnston G, et al. A new world malaria map: Plasmodium falciparum endemicity in 2010. Malar J. 2011;10:378.
24. Cairns M, Roca-Feltrer A, Garske T, Wilson AL, Diallo D, Milligan PJ, et al. Estimating the potential public health impact of seasonal malaria chemoprevention in African children. Nat Commun. 2012;3:881.
25. Flaxman AD, Fullman N, Otten MW Jr, Menon M, Cibulskis RE, Ng M, et al. Rapid scaling up of insecticide-treated bed net coverage in Africa and its relationship with development assistance for health: a systematic synthesis of supply, distribution, and household survey data. PLoS Med. 2010;7:e1000328.
26. Cohen JM, Woolsey AM, Sabot OJ, Gething PW, Tatem AJ, Moonen B. Optimizing investments in malaria treatment and diagnosis. Science. 2012;338:612-4.
27. WHO. World malaria report 2012. Geneva: World Health Organization; 2012.
28. Mohammed A, Ndaro A, Kalinga A, Manjurano A, Mosha J, Mosha D, et al. Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania. Malar J. 2013;12:415.
29. van Schalkwyk DA, Sutherland CJ. Malaria resistance to non-artemisinin partner drugs: how to reACT. Lancet Infect Dis. 2015;15:621-3.
30. Bivand R, Lewin-Koh N. Maptools: tools for reading and handling spatial objects. R package version 0.8-29. 2014. http://CRAN.R-project.org/package=maptools.